May 25, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Sangi to Launch High-Functional Nano-tech Toothpaste in 2004
 

Tokyo, Nov 19, 2003 (JCN) - Japanese toothpaste manufacturer Sangi has developed a new technology to control ultrafine particles. Using this technology, the company has developed more sophisticated toothpaste that is highly effective in re-calcifying and whitening teeth.

Sangi will start to distribute the new toothpaste, brand-named "New-Apagard," in April 2004.

By Aki Tsukioka Contributor

Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.



ACN Newswire

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Kaneka Confirms Positive Effect of Q10 Against Fatigue (Dec 3, 2012)
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)